228 related articles for article (PubMed ID: 31930805)
1. [RITUXIMAB FOR THE TREATMENT OF PEMPHIGUS - A REVIEW OF RECENT STUDIES AND PERSONAL EXPERIENCE FROM THE RABIN MEDICAL CENTER AND THE SHEBA MEDICAL CENTER].
Mimouni D; Baum S
Harefuah; 2020 Jan; 159(1):31-33. PubMed ID: 31930805
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of severe refractory pemphigus vulgaris with rituximab].
Pitarch G; Sánchez-Carazo JL; Pardo J; Torrijos A; Roche E; Fortea JM
Actas Dermosifiliogr; 2006; 97(1):48-51. PubMed ID: 16540052
[TBL] [Abstract][Full Text] [Related]
3. [Successful treatment of pemphigus foliaceus with rituximab. Report of 3 cases].
Alter M; Wittmann M; Völker B; Kapp A; Werfel T; Gutzmer R
Hautarzt; 2009 Sep; 60(9):743-8. PubMed ID: 19151961
[TBL] [Abstract][Full Text] [Related]
4. Rituximab for autoimmune blistering diseases: recent studies, new insights.
Lunardon L; Payne AS
G Ital Dermatol Venereol; 2012 Jun; 147(3):269-76. PubMed ID: 22648328
[TBL] [Abstract][Full Text] [Related]
5. Rituximab Therapy for Childhood Pemphigus Vulgaris.
Kincaid L; Weinstein M
Pediatr Dermatol; 2016; 33(2):e61-4. PubMed ID: 26765543
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of refractory childhood pemphgus vulgaris with anti-CD20 monoclonal antibody (rituximab).
Kong HH; Prose NS; Ware RE; Hall RP
Pediatr Dermatol; 2005; 22(5):461-4. PubMed ID: 16191003
[TBL] [Abstract][Full Text] [Related]
7. Rituximab and pemphigus--a therapeutic advance.
Diaz LA
N Engl J Med; 2007 Aug; 357(6):605-7. PubMed ID: 17687137
[No Abstract] [Full Text] [Related]
8. Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil.
Biot Sdel R; Franco JP; Lima RB; Pereira HN; Marques LP; Martins CJ
An Bras Dermatol; 2014; 89(6):980-4. PubMed ID: 25387507
[TBL] [Abstract][Full Text] [Related]
9. Childhood pemphigus vulgaris successfully treated with rituximab.
Kanwar AJ; Sawatkar GU; Vinay K; Hashimoto T
Indian J Dermatol Venereol Leprol; 2012; 78(5):632-4. PubMed ID: 22960821
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant rituximab therapy in pemphigus: a single-center experience of 18 cases.
Baum S; Gilboa S; Greenberger S; Pavlotsky F; Trau H; Barzilai A
J Dermatolog Treat; 2013 Dec; 24(6):427-30. PubMed ID: 23521340
[TBL] [Abstract][Full Text] [Related]
11. Clinical and biological activity of rituximab in the treatment of pemphigus.
Bohelay G; Caux F; Musette P
Immunotherapy; 2021 Jan; 13(1):35-53. PubMed ID: 33045883
[TBL] [Abstract][Full Text] [Related]
12. Rituximab in severe pemphigus.
Schmidt E; Goebeler M; Zillikens D
Ann N Y Acad Sci; 2009 Sep; 1173():683-91. PubMed ID: 19758216
[TBL] [Abstract][Full Text] [Related]
13. [Rituximab (anti-CD20) for the treatment of autoimmune bullous diseases].
Kasperkiewicz M; Zillikens D
Hautarzt; 2007 Feb; 58(2):115-6, 118-21. PubMed ID: 17237928
[TBL] [Abstract][Full Text] [Related]
14. [Rituximab induced remission of pemphigus vulgaris: 2 cases].
Borel C; Launay F; Garrouste C; Astudillo L; Bazex J; Arlet P; Paul C; Viraben R; Sailler L
Rev Med Interne; 2007 Apr; 28(4):266-8. PubMed ID: 17188405
[TBL] [Abstract][Full Text] [Related]
15. Severe multi-resistant pemphigus vulgaris: prolonged remission with a single cycle of rituximab.
Corral IS; Freitas TH; Aquino RT; Koller DA; Magliari ME; Muller H
An Bras Dermatol; 2013; 88(4):639-42. PubMed ID: 24068143
[TBL] [Abstract][Full Text] [Related]
16. Rituximab for treatment-refractory pemphigus and pemphigoid: a case series of 17 patients.
Kasperkiewicz M; Shimanovich I; Ludwig RJ; Rose C; Zillikens D; Schmidt E
J Am Acad Dermatol; 2011 Sep; 65(3):552-558. PubMed ID: 21641080
[TBL] [Abstract][Full Text] [Related]
17. Clinical observation of different doses of rituximab for the treatment of severe pemphigus: A single-center prospective cohort study.
Zhang J; Huang X; Zhang Z; Zhao P; Chen W; Liang Y; Liu H; Zhong Z; Chen Y
J Am Acad Dermatol; 2023 Feb; 88(2):500-502. PubMed ID: 35779637
[No Abstract] [Full Text] [Related]
18. Rituximab in pemphigus.
Hebert V; Joly P
Immunotherapy; 2018 Jan; 10(1):27-37. PubMed ID: 29064314
[TBL] [Abstract][Full Text] [Related]
19. Crescendo response to rituximab in oral pemphigus vulgaris: a case with 7-year follow-up.
Greenblatt DT; Benton EC; Groves RW; Setterfield JF
Clin Exp Dermatol; 2016 Jul; 41(5):529-32. PubMed ID: 27061201
[TBL] [Abstract][Full Text] [Related]
20. Therapy with rituximab for autoimmune pemphigus: results from a single-center observational study on 42 cases with long-term follow-up.
Cianchini G; Lupi F; Masini C; Corona R; Puddu P; De Pità O
J Am Acad Dermatol; 2012 Oct; 67(4):617-22. PubMed ID: 22243765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
